“Our most serious concern re ALL the gene-based vaccines is that you convey the impression that cerebral venous sinus thrombosis (CVST) [ed. blood-clot formation in the brain’s venous sinuses] is a very rare adverse event. In fact the opposite is probably true. The cardinal symptoms of CVST dominate the list of adverse reactions: piercing headache, nausea and vomiting, impaired consciousness, impaired speech, impaired vision, impaired hearing, paralysis of varying degrees in various locations, and loss of motor control (including such severe loss that victims mimic the symptoms of Huntington’s Chorea). It is imperative that proper medical attention is given to every individual who presents with any of the above symptoms. It is the indirigible duty of the European Medicines Agency to disseminate the above information to medical doctors and responsible authorities…
A further serious concern is that peripheral ‘clot’ formation is not alluded to by you at all. It is evident that ‘clot’ formation in the deep veins of the legs and arms can lead to life-threatening pulmonary embolism. Further, thrombus formation in the small vessels of the lungs can lead to a clinical picture resembling atypical pneumonia. In addition, it is vitally important to understand that any one of 1a. 1b. 1c. or any combination of these can lead via consumption of coagulation factors to the clinical picture of disseminated intravascular coagulation (DIC) which is actually characterised by massive bleeding events into the skin and into other organs of the body. It is imperative that all the above diagnoses are actively searched for and that all cases displaying symptoms consistent with any of these diagnoses are recorded properly as adverse vaccine-related events.
1e. Furthermore, long term adverse effects, in particular the danger of immune dependant [sic] enhancement of disease and adverse effects of subsequent vaccinations are impossible to predict. The European Medicines Agency, as the regulator re. vaccines for almost 450 million people across 27 European Union member states, must inform the public and the relevant authorities of this profoundly important issue.”